Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant (Q37056103)

18 August 2017

Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant (English)

1 reference

progressive multifocal leukoencephalopathy

18 August 2017

0 references

1 reference

1 reference

2

Tereza Martinu

1 reference

18 August 2017

Jesse Waggoner

1

1 reference

PMC publication ID

3727631

18 August 2017

Scott M Palmer

series ordinal

3

1 reference

18 August 2017

1 April 2009

1 reference

The Journal of Heart and Lung Transplantation

18 August 2017

1 reference

18 August 2017

28

1 reference

18 August 2017

4

1 reference

18 August 2017

395-398

1 reference

Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

Progressive multifocal leukoencephalopathy in transplant recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

Progressive multifocal leukoencephalopathy in a lung transplant recipient

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

A reversible posterior leukoencephalopathy syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

Visual symptoms after lung transplantation: a case of progressive multifocal leukoencephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

Long-term cell monitoring of kidney recipients after an antilymphocyte globulin induction with and without steroids.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3727631

Treatment of refractory acute rejection in a lung transplant recipient with campath 1H

4 December 2018

1 reference

12 December 2020

Opportunistic Infections in 547 Organ Transplant Recipients Receiving Alemtuzumab, a Humanized Monoclonal CD-52 Antibody

1 reference

12 December 2020

Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent steroid-resistant heart transplant rejection

1 reference

12 December 2020

Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera

1 reference

12 December 2020

Alemtuzumab (Campath-1H) induction in a pediatric heart transplant: successful outcome and rationale for its use

1 reference

12 December 2020

10.1016/J.HEALUN.2008.12.010

Identifiers

DOI

1 reference

18 August 2017

1 reference

PMC publication ID

3727631

18 August 2017

PubMed publication ID

19332268

1 reference

PMC publication ID

3727631